Iran Actover co. made Actiramer glatiramer acetate for MS patients داروي اكتيرامر بيماران ام اس

October 25, 2018 (Persian calendar 1397/8/3)

Actover company (شركت اكتوور) official website

http://www.actoverco.com

Alborz province (استان البرز)

http://en.wikipedia.org/wiki/Alborz_Province

Karaj county (شهرستان كرج)

http://en.wikipedia.org/wiki/Karaj_County

Kamal-Shahr city (كمالشهر)

http://en.wikipedia.org/wiki/Kamal_Shahr

Glatiramer acetate (also known as Copolymer 1, Cop-1, or Copaxone) is an immunomodulator medication currently used to treat multiple sclerosis.

Glatiramer acetate is approved in the United States to reduce the frequency of relapses, but not for reducing the progression of disability.

Observational studies, but not randomized controlled trials, suggest that it may reduce progression of disability.

While a conclusive diagnosis of multiple sclerosis requires a history of two or more episodes of symptoms and signs, glatiramer acetate is approved to treat a first episode anticipating a diagnosis.

It is also used to treat relapsing-remitting multiple sclerosis. It is administered by subcutaneous injection.

It is a mixture of random-sized peptides that are composed of the four amino acids found in myelin basic protein, namely glutamic acid, lysine, alanine, and tyrosine.

Myelin basic protein is the antigen in the myelin sheaths of the neurons that stimulates an autoimmune reaction in people with MS, so the peptide may work as a decoy for the attacking immune cells.

Iran Actover co. made Actiramer glatiramer acetate pharmaceutical for Multiple sclerosis (MS) patients

داروي اكتيرامر براي بيماران ام اس ايران